In ER-Positive, HER2-Negative Breast Cancers, HER2 mRNA Levels Correlate Better with Clinicopathologic Features and Oncotype DX Recurrence Score than HER2 Immunohistochemistry
- Resource Type
- Article
- Source
- In
Laboratory Investigation March 2024 104(3) - Subject
- Language
- ISSN
- 0023-6837